Events
For the First Time in the Arab Republic of Egypt and the African Continent EDA Achieves ISO/IEC 17025 Accreditation for the First HPLC Calibration Laboratory in Egypt and Africa
The Egyptian Drug Authority (EDA) has achieved a new milestone in advancing its pharmaceutical regulatory system, with the Calibration Laboratory of the Maintenance and Calibration Department, under the Central Administration for Drug Control, obtaining accreditation from the Egyptian Accreditation Council (EGAC) for the calibration of High-Performance Liquid Chromatography (HPLC) systems equipped with Ultraviolet (UV) Detectors, in accordance with the requirements of the international standard ISO/IEC 17025. The accreditation was granted following the successful completion of the assessment conducted by EGAC, making it the first accredited laboratory of its kind in the Arab Republic of Egypt and across the African continent.
This accreditation reflects the Egyptian Drug Authority’s commitment to implementing the highest standards of quality and technical competence, as well as its continuous efforts to strengthen its regulatory infrastructure and enhance the capabilities of its laboratories in line with international best practices and standards. These efforts support the efficiency of the pharmaceutical regulatory system and keep pace with the latest global developments.
During the assessment process, the evaluation team from the Egyptian Accreditation Council commended the EDA’s calibration system as an exemplary model, recognizing it as an advanced application of quality management systems that demonstrates a high level of institutional competence and aligns with Egypt’s vision for developing the healthcare sector and improving the quality of services.
The assessment team was received by Dr. Wedyan Younis, Head of the Central Administration for Drug Control; Dr. Marwa Shaheen, General Manager of Technical Support; Dr. Elshaymaa Abou Bakr, Director of the Maintenance and Calibration Department; Dr. Walaa Said, Head of the Quality Assurance Unit; Dr. Mariam Mohamed, Head of the Calibration Laboratory; Dr. Lamees Ashraf, Technical Supervisor for the Accreditation Scope; and Dr. Nancy Nagy, Quality Coordinator of the Calibration Laboratory.
This accreditation represents a strategic step toward enhancing the accuracy and reliability of laboratory testing results by ensuring that calibration activities are performed in full compliance with the requirements of ISO/IEC 17025. It contributes to improving the efficiency of the pharmaceutical regulatory system while strengthening the quality, safety, and efficacy of pharmaceutical products available on the Egyptian market. It also reflects the professionalism and extensive technical expertise of the Calibration Laboratory team, which has accumulated more than 15 years of experience in accredited calibration services.
Furthermore, this achievement opens new opportunities for the Egyptian Drug Authority to strengthen the international recognition of its laboratory capabilities and reinforce confidence in Egypt’s national regulatory system. It supports the state's efforts to enhance the quality of healthcare services, improve the competitiveness of the Egyptian pharmaceutical industry, and promote pharmaceutical exports through reliance on internationally accredited laboratories.
The Egyptian Drug Authority reaffirms its commitment to continuously enhancing its technical and technological capabilities and strengthening its quality and accreditation systems in pursuit of the highest levels of institutional excellence. These efforts reinforce confidence in Egypt’s pharmaceutical regulatory framework, in accordance with international best practices and standards, while contributing to the protection of public health and ensuring the quality, safety, and efficacy of pharmaceutical products.
Tags
ISO/IEC 17025
EDA